In patients who did not receive prestudy heparin , the incidences of recurrent VTE were similar in rivaroxaban ( @ of @ , @ % ) and enoxaparin/VKA ( @ of @ , @ % ) patients ( adjusted hazard ratio -LSB- HR -RSB- = @ ; @ % confidence interval -LSB- CI -RSB- = @ to @ ) .